Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GNPX Genprex, Inc.

已收盘 09-18 16:00:00 EDT

0.3650

+0.0250

+7.35%

盘后0.3476

-0.0174-4.77%

19:48 EDT

最高0.3800	最低0.2806	成交量31.56万
今开0.3340	昨收0.3400	日振幅29.24%
总市值131.35万	流通市值123.03万	总股本359.85万
成交额10.76万	换手率9.36%	流通股本337.07万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":0.365,"timestamp":1726689600000,"preClose":0.34,"halted":0,"volume":315598,"hourTrading":{"tag":"盘后","latestPrice":0.3476,"preClose":0.365,"latestTime":"19:48 EDT","volume":1179,"amount":415.25455,"timestamp":1726703328391},"delay":0,"floatShares":3370700,"shares":3598500,"eps":-15.566147,"marketStatus":"已收盘","marketStatusCode":5,"change":0.025,"latestTime":"09-18 16:00:00 EDT","open":0.334,"high":0.38,"low":0.2806,"amount":107642.8718882,"amplitude":0.292353,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-15.566147,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726732800000},"adr":0,"listingDate":1522296000000,"adjPreClose":0.34,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.334,"preClose":0.34,"latestTime":"09:23 EDT","volume":4005,"amount":1478.5618149,"timestamp":1726665835848},"postHourTrading":{"tag":"盘后","latestPrice":0.3476,"preClose":0.365,"latestTime":"19:48 EDT","volume":1179,"amount":415.25455,"timestamp":1726703328391},"volumeRatio":0.115166,"impliedVol":5.668,"impliedVolPercentile":0.9896},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2468819445","title":"Genprex, Inc.盘中异动 股价大跌5.88%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468819445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468819445?lang=zh_cn&edition=full","pubTime":"2024-09-18 21:30","pubTimestamp":1726666237,"startTime":"0","endTime":"0","summary":"北京时间2024年09月18日21时30分，Genprex, Inc.股票出现异动，股价急速下挫5.88%。截至发稿，该股报0.320美元/股，成交量1.9165万股，换手率0.74%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918213037ab645dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918213037ab645dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2467428848","title":"Genprex, Inc.盘中异动 早盘大幅下跌7.14%报0.390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467428848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467428848?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:30","pubTimestamp":1726493411,"startTime":"0","endTime":"0","summary":"北京时间2024年09月16日21时30分，Genprex, Inc.股票出现异动，股价快速下跌7.14%。截至发稿，该股报0.390美元/股，成交量45.5197万股，换手率17.59%，振幅7.95%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091621301198e37a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091621301198e37a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2461594785","title":"Genprex, Inc.盘中异动 大幅下跌5.77%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461594785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461594785?lang=zh_cn&edition=full","pubTime":"2024-08-23 21:42","pubTimestamp":1724420560,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日21时42分，Genprex, Inc.股票出现波动，股价急速下挫5.77%。截至发稿，该股报0.660美元/股，成交量1.6784万股，换手率0.65%，振幅2.87%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082321424097199c7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082321424097199c7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2461293418","title":"Genprex, Inc.盘中异动 早盘股价大涨6.06%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461293418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461293418?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:37","pubTimestamp":1724247475,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日21时37分，Genprex, Inc.股票出现异动，股价快速上涨6.06%。截至发稿，该股报0.700美元/股，成交量2.502万股，换手率0.97%，振幅4.55%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821213756ab5edd04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821213756ab5edd04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2460022350","title":"Genprex, Inc.盘中异动 股价大跌6.25%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460022350","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460022350?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:49","pubTimestamp":1724161741,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时49分，Genprex, Inc.股票出现异动，股价急速跳水6.25%。截至发稿，该股报0.600美元/股，成交量6.0586万股，换手率2.34%，振幅7.81%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202149029f3e3f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202149029f3e3f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2459420375","title":"Genprex, Inc.盘中异动 大幅上涨10.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420375","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420375?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728705,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Genprex, Inc.股票出现异动，股价急速上涨10.24%。截至发稿，该股报0.805美元/股，成交量10.2783万股，换手率3.97%，振幅3.56%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213145959b9f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213145959b9f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2459172401","title":"Genprex, Inc.盘中异动 大幅上涨23.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459172401","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459172401?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:31","pubTimestamp":1723642318,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时31分，Genprex, Inc.股票出现异动，股价急速上涨23.38%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Conduit Pharmaceuticals Inc.、Genprex, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为49.21%、42.92%、30.63%，振幅较大的相关个股有Genprex, Inc.、Cadrenal Therapeutics, Inc.、Cormedix Inc.，振幅分别为24.68%、14.00%、13.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131589f2ac12d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131589f2ac12d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2459909658","title":"Genprex, Inc.盘中异动 早盘急速下跌13.49%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459909658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459909658?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:30","pubTimestamp":1723555826,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时30分，Genprex, Inc.股票出现波动，股价大幅下挫13.49%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，冠科美博、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Genprex, Inc.、冠科美博、Psyence Biomedical Ltd.较为活跃，换手率分别为105.72%、61.27%、18.31%，振幅较大的相关个股有Oragenics Inc.、Ovid Therapeutics Inc.、Ginkgo Bioworks Holdings, Inc.，振幅分别为4.86%、3.52%、2.98%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213026a1d43374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213026a1d43374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2458518768","title":"Genprex, Inc.盘中异动 急速拉升5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458518768","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458518768?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:35","pubTimestamp":1723217734,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日23时35分，Genprex, Inc.股票出现波动，股价急速上涨5.76%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为2.44%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809233534af96d5a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809233534af96d5a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2457584947","title":"Genprex, Inc.盘中异动 早盘股价大涨6.38%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457584947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457584947?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037512,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Genprex, Inc.股票出现波动，股价急速拉升6.38%。截至发稿，该股报1.50美元/股，成交量5500股，换手率0.26%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131529585f100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131529585f100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2457770837","title":"Genprex, Inc.盘中异动 快速下挫5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457770837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457770837?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:33","pubTimestamp":1722872031,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日23时33分，Genprex, Inc.股票出现异动，股价急速跳水5.73%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805233352941fe3e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805233352941fe3e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2454760738","title":"Genprex, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454760738","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454760738?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:31","pubTimestamp":1721914310,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时31分，Genprex, Inc.股票出现波动，股价急速上涨5.26%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213150955a4451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213150955a4451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2452454942","title":"Genprex, Inc.盘中异动 临近收盘大幅拉升5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452454942","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452454942?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:58","pubTimestamp":1721159897,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时58分，Genprex, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报2.08美元/股，成交量2.1833万股，换手率1.04%，振幅4.80%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717035817aef9f8d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717035817aef9f8d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2448918011","title":"Genprex, Inc.盘中异动 急速拉升5.57%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448918011","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448918011?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:32","pubTimestamp":1719840732,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时32分，Genprex, Inc.股票出现波动，股价快速拉升5.57%。截至发稿，该股报1.99美元/股，成交量1507股，换手率0.07%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213212955f51a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213212955f51a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2446683485","title":"Genprex, Inc.盘中异动 股价大涨6.32%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683485","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446683485?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:30","pubTimestamp":1719581443,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时30分，Genprex, Inc.股票出现异动，股价急速上涨6.32%。截至发稿，该股报2.09美元/股，成交量317股，换手率0.02%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821304396817fd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821304396817fd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2446556870","title":"Genprex, Inc.盘中异动 早盘快速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556870","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446556870?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:44","pubTimestamp":1719495869,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时44分，Genprex, Inc.股票出现波动，股价大幅上涨6.12%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214430941f1d27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214430941f1d27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2446399730","title":"Genprex, Inc.盘中异动 大幅拉升6.13%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446399730","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446399730?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:55","pubTimestamp":1719410103,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时55分，Genprex, Inc.股票出现异动，股价快速拉升6.13%。截至发稿，该股报2.17美元/股，成交量7101股，换手率0.34%，振幅1.37%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621550396817179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062621550396817179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2445795074","title":"Genprex, Inc.盘中异动 早盘大幅拉升7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445795074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445795074?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:40","pubTimestamp":1719236449,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时40分，Genprex, Inc.股票出现异动，股价急速上涨7.92%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214049aef6514c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214049aef6514c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2443675825","title":"Genprex, Inc.盘中异动 急速下跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675825","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443675825?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:56","pubTimestamp":1718373408,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时56分，Genprex, Inc.股票出现异动，股价急速下挫5.62%。截至发稿，该股报2.28美元/股，成交量1.0057万股，换手率0.48%，振幅6.20%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215648af8da292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215648af8da292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2441069125","title":"Genprex, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441069125","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441069125?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:36","pubTimestamp":1717767394,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时36分，Genprex, Inc.股票出现异动，股价大幅跳水5.12%。截至发稿，该股报2.60美元/股，成交量3619股，换手率0.17%，振幅2.19%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213634aef410ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213634aef410ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":-0.2545},{"period":"1month","weight":-0.4753},{"period":"3month","weight":-0.8365},{"period":"6month","weight":-0.8874},{"period":"1year","weight":-0.9809},{"period":"ytd","weight":-0.963}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司，为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司，开发一种新的方法来治疗癌症，根据其新的专利技术平台，包括其最初的候选产品，Oncoprex免疫基因治疗提供，或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因，然后静脉内施用并被肿瘤细胞摄取，其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制，其中断细胞信号通路，其引起癌细胞的复制和增殖，重新建立癌细胞中凋亡途径或程序性细胞死亡途径，并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.912357},{"month":2,"riseRate":0.5,"avgChangeRate":0.15537},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.179543},{"month":4,"riseRate":0.285714,"avgChangeRate":0.230015},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02727},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.121366},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.165011},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.112826},{"month":9,"riseRate":0,"avgChangeRate":-0.194838},{"month":10,"riseRate":0,"avgChangeRate":-0.215282},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.138223},{"month":12,"riseRate":0.5,"avgChangeRate":0.020272}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}